Ray Dalio
JAZZ icon

Ray Dalio’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ray Dalio’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-250,947
Closed -$31.2M – 659
2025
Q1 		$31.2M Buy
250,947
+58,912
+31% +$7.69M 0.14% 128
2024
Q4 		$23.6M Buy
192,035
+79,036
+70% +$9.32M 0.11% 143
2024
Q3 		$12.6M Buy
112,999
+11,864
+12% +$1.3M 0.07% 229
2024
Q2 		$10.8M Sell
101,135
-8,656
-8% -$952K 0.06% 242
2024
Q1 		$13.2M Buy
109,791
+19,375
+21% +$2.37M 0.07% 215
2023
Q4 		$11.1M Buy
90,416
+2,640
+3% +$329K 0.06% 230
2023
Q3 		$11.4M Buy
87,776
+76,599
+685% +$10.2M 0.07% 220
2023
Q2 		$1.39M Buy
+11,177
New +$1.5M 0.01% 529
2023
Q1 		– Sell
-3,373
Closed -$537K – 805
2022
Q4 		$537K Sell
3,373
-24,850
-88% -$3.64M ﹤0.01% 714
2022
Q3 		$3.76M Buy
+28,223
New +$4.29M 0.02% 441
2021
Q4 		– Sell
-2,200
Closed -$286K – 774
2021
Q3 		$286K Buy
+2,200
New +$332K ﹤0.01% 639
2021
Q1 		– Sell
-2,255
Closed -$372K – 534
2020
Q4 		$372K Buy
+2,255
New +$336K ﹤0.01% 485

Other funds holding JAZZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Ray Dalio's JAZZ Position: Q2 2025 in Review

Ray Dalio sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2025, closing a stake of 250,947 shares — an estimated $31.2M sold.

Ray Dalio first reported a position in JAZZ in Q4 2020 and held it in 12 quarters. The position peaked at $31.2M in Q1 2025. 501 funds tracked by Wall St. Rank hold JAZZ as of Q2 2025.

  • Ray Dalio reported no remaining Jazz Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • Ray Dalio sold 250,947 Jazz Pharmaceuticals shares in Q2 2025, an estimated $31.2M.
  • Ray Dalio first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 12 quarters.
  • Ray Dalio's Jazz Pharmaceuticals position peaked at $31.2M in Q1 2025.
  • 501 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2025.

Based on Bridgewater Associates's 13F filing for Q2 2025, filed 13 Aug 2025.